These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15688751)

  • 21. [The side effects of antiretroviral therapy].
    Hartmann M
    Hautarzt; 2006 Nov; 57(11):969-74. PubMed ID: 17036249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial studies in HAART-related lipodystrophy: from experimental hypothesis to clinical findings.
    Miró O; López S; Cardellach F; Casademont J
    Antivir Ther; 2005; 10 Suppl 2():M73-81. PubMed ID: 16152708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Side effects of HIV therapy.
    Esser S; Helbig D; Hillen U; Dissemond J; Grabbe S
    J Dtsch Dermatol Ges; 2007 Sep; 5(9):745-54. PubMed ID: 17760894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of adverse events associated with antiretroviral therapy and the relationship to treatment adherence.
    Lenzi L; Wiens A; Pontarolo R
    Int J Clin Pharmacol Ther; 2013 Feb; 51(2):141-6. PubMed ID: 23253950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
    Calza L; Manfredi R; Chiodo F
    J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
    Falutz J
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection.
    Samaras K
    J Antimicrob Chemother; 2008 Feb; 61(2):238-45. PubMed ID: 18070830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity.
    ter Hofstede HJ; Burger DM; Koopmans PP
    Neth J Med; 2003 Dec; 61(12):393-403. PubMed ID: 15025414
    [No Abstract]   [Full Text] [Related]  

  • 29. [Metabolic complications associated with use of protease inhibitors].
    Mosnier-Pudar H
    Ann Med Interne (Paris); 2000 Jun; 151(4):278-82. PubMed ID: 10922955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic complications of antiretroviral therapy.
    Sweet DE
    Top HIV Med; 2005; 13(2):70-4. PubMed ID: 16082057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sweetening the toxic cocktail. Managing the side effects of HIV medications.
    Doerfler RE
    Adv Nurse Pract; 2002 May; 10(5):52-4, 57-8, 103. PubMed ID: 12420531
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolic effects of protease inhibitor therapy.
    Bernasconi E
    AIDS Read; 1999 Jul; 9(4):254-6, 259-60, 266-9. PubMed ID: 12737115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic toxicities of antiretroviral therapy.
    Herman JS; Easterbrook PJ
    Int J STD AIDS; 2001 Sep; 12(9):555-62; quiz 563-4. PubMed ID: 11516363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
    Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.
    Nolan D; Mallal S
    J HIV Ther; 2004 May; 9(2):34-40. PubMed ID: 15238874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance and HIV infection: a review.
    Aboud M; Elgalib A; Kulasegaram R; Peters B
    Int J Clin Pract; 2007 Mar; 61(3):463-72. PubMed ID: 17313615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic complications associated with antiretroviral therapy.
    Jain RG; Furfine ES; Pedneault L; White AJ; Lenhard JM
    Antiviral Res; 2001 Sep; 51(3):151-77. PubMed ID: 11448728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
    Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
    HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic abnormalities in patients with HIV infection].
    Rodríguez-Carranza SI; Aguilar-Salinas CA
    Rev Invest Clin; 2004; 56(2):193-208. PubMed ID: 15377073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AIDS-related lipodystrophy/insulin resistance syndrome.
    Kino T; Mirani M; Alesci S; Chrousos GP
    Horm Metab Res; 2003 Mar; 35(3):129-36. PubMed ID: 12734771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.